$FLEX

OFFER DAVID SCOTT sold $1.1M of FLEX

OFFER DAVID SCOTT (EVP, General Counsel) sold 7,223 shares of FLEX LTD. (FLEX) at an average of $148.01 ($146.00–$149.60, $1.07M total) across 5 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · OFFER DAVID SCOTT
Published Jun 18, 2026, 12:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 18, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FLEX
Neutral
medium confidence
Mentioned
$FLEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FLEXNeutralLow
01

Why it matters

The disclosure provides a concrete, dated insider selling event and transaction size, but the 10b5-1 designation typically lowers the probability that the sale conveys new negative fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing is unlikely to be a standalone price catalyst given the pre-arranged nature of the trades.

03

What to watch

The article doesn’t state whether the sale was part of a larger multi-tranche program, nor does it provide context on total insider holdings changes beyond the post-transaction figure.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-17 for a 2026-06-15 sale

Background

This is an SEC Form 4 insider transaction for FLEX, reporting an officer’s open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$FLEXNeutralMedium confidence
Context

FLEX’s EVP & General Counsel Offer David Scott sold 7,223 shares in an open-market transaction totaling about $1.07M under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be modest and sentiment-driven rather than catalyst-driven.

Evidence & confidence

The filing is a routine Form 4 insider sale with explicit 10b5-1 pre-arrangement, reducing the likelihood of immediate information content beyond normal portfolio rebalancing.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with internal caution; traders may treat it as a mild bearish signal if other negative catalysts exist (not provided here).

Key entities

  • FLEX

    Issuer of the Form 4 insider transaction; EVP & General Counsel Offer David Scott sold shares totaling ~$1.07M.

  • Offer David Scott

    EVP, General Counsel at FLEX; sold 7,223 shares across five trades on 2026-06-15 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FLEXHighAI 9/10

Why is Flex stock surging today?

Flex (FLEX) stock rose 8.6% pre-market after Q2 2027 earnings beat estimates, with EPS at $1.18 vs. $1.06 and revenue at $8.5B vs. $8.17B. Management raised FY2027 guidance, and BofA reiterated a Buy rating. The stock had previously fallen below its 52-week high of $166.86.

$FLEXMedAI 9/10

Flex earnings beat by $0.12, revenue topped estimates

Flex reported Q2 EPS of $1.18, beating estimates by $0.12, with revenue at $8.5B, exceeding expectations. The company forecasted FY 2027 EPS of $4.84-$5.16 and revenue of $34.90B-$35.90B. Shares are down 26.73% over 3 months but up 26.10% year-over-year, with a 'fair performance' financial health score.

$FLEXHighAI 9/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

FLEX LTD. (FLEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. P R E S S R E L E A S E EXHIBIT 99.1 FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS • Reported Q2 net sales of $8.5 billion, up 25% versus the prior year. • Delivered Q2 GAAP operating margin of 4.9%, and adjusted operating margin of 7.1%. • Reported Q2 GAAP EPS of $0.70, and re

$FLEXMedAI 8/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

Flex reported Q2 2027 net sales of $8.5B, up 25% YoY. GAAP EPS was $0.70, adjusted EPS $1.18. CEO Revathi Advaithi highlighted growth and a planned spin-off. Q3 guidance: sales $8.87B-$9.17B, adjusted EPS $1.19-$1.25. FY2027 guidance updated to sales $34.9B-$35.9B, adjusted EPS $4.84-$5.16.